Prof. Arnon Kater -State of the art therapy in CLL CME Congresses . Prof. Arnon Kater -State of the art therapy in CLL Annalisa Ruggeri – Haplo versus matched unrelated transplant at the era of post-cyclophosphamide ? CME Congresses . Annalisa Ruggeri – Haplo versus matched unrelated transplant at the era of post-cyclophosphamide ? Robert Zeiser – REACH3 trial results CME Congresses . Robert Zeiser – REACH3 trial results Christopher Hourigan – How to distinguish to Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis? CME Congresses . Christopher Hourigan – How to distinguish to Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis? Alex Lazaryan – Belumosudil’s FDA approval for cGVHD CME Congresses . Alex Lazaryan – Belumosudil’s FDA approval for cGVHD Monzr Al Malki – The role of post cyclophosphamide, for GVHD prophylaxis, in the mismatched unrelated setting CME Congresses . Monzr Al Malki – The role of post cyclophosphamide, for GVHD prophylaxis, in the mismatched unrelated setting JNaveen Pemmaraju – Novel Therapeutic Approaches in BPDCN CME Congresses . JNaveen Pemmaraju – Novel Therapeutic Approaches in BPDCN Anna Sureda – Therapy of lymphomas, what’s new at EHA 2021 CME Congresses . Anna Sureda – Therapy of lymphomas, what’s new at EHA 2021 Jurgen Kuball – Gammadelta T cells CME Congresses . Jurgen Kuball – Gammadelta T cells Nitin Jain – Therapy of CLL, what’s new at EHA 2021 CME Congresses . Nitin Jain – Therapy of CLL, what’s new at EHA 2021 Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23
